The expression of the protein <i>Mesothelin (MSLN)</i> is highly variable in several malignancies including colorectal cancer (CRC) and high levels are associated with aggressive clinicopathological features and worse patient survival. This evidence concerns the gene MSLN and colorectal cancer.